Sichuan Hebang Biotechnology Stock Debt To Equity

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

According to the company disclosure, Sichuan Hebang Biotechnology has a Debt To Equity of 0.0%. This is 100.0% lower than that of the Chemicals sector and about the same as Materials (which currently averages 0.0) industry. The debt to equity for all China stocks is 100.0% higher than that of the company.

The Macroaxis Fundamental Analysis modules help investors analyze Sichuan Hebang Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sichuan Hebang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sichuan Hebang Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Sichuan Hebang financial ratios help investors to determine whether Sichuan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sichuan with respect to the benefits of owning Sichuan Hebang security.